Biocon Biologics

May this #Eid bring you good health, happiness, and prosperity. #BioconGroup wishes you a joyous and blessed Eid! #EidMubarak #EidMubarak2025

Usher in prosperity and new beginnings! May this #Ugadi bring joy, success, and good health. Wishing you a #HappyUgadi!

𝐋𝐚𝐬𝐭 𝐅𝐞𝐰 𝐒𝐞𝐚𝐭𝐬 𝐋𝐞𝐟𝐭! 𝐒𝐞𝐚𝐭𝐬 𝐚𝐫𝐞 𝐟𝐢𝐥𝐥𝐢𝐧𝐠 𝐟𝐚𝐬𝐭 𝐟𝐨𝐫 𝐁𝐚𝐭𝐜𝐡 𝟐𝟗 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐢𝐨𝐜𝐨𝐧 𝐊𝐆𝐈 𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐞 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 𝐢𝐧 𝐁𝐢𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬. Batch Launch Date: 𝐀𝐩𝐫𝐢𝐥 𝟐𝟒𝐭𝐡, 𝟐𝟎𝟐𝟓 Why Choose This Program? 👉 Learn from top biotech professionals, Biocon experts & KGI faculty 👉 Receive mentorship from industry leaders 👉 Gain hands-on training at Biocon facilities 👉 Enhance your career with professional development sessions 👉 100% interview opportunities Apply today at https://bit.ly/3Zu1Ez8 #admissions #biology #biosciences #biotechnology #biochemistry #careers #engineers #freshers #lifesciences #microbiology #opportunities #pharma #technology

What makes us happy? We're not done talking about it yet! It is the purpose we find in our work, the moments we treasure outside of it, and anything in between. Learn more about the work we do and how we're creating an impact: https://lnkd.in/gdZufzdf Colleen Roache, CPC  Reeya Chunn Andrew R. Samuel, M.D.  @lauren-maccallum

Biocon Biologics  is heading to  CPHI Japan2025. As a partner-led company in Japan, we are committed to expanding access to high-quality biosimilars. Let’s connect at Booth 6F-34 to discuss how we’re shaping the future of healthcare. See you there. #AdvancingAccess #CPHIJapan2025 #explore

Wishing a very happy birthday to a leader whose vision has redefined healthcare. Through innovation and perseverance, Kiran Mazumdar Shaw has not only built a legacy but has also brought hope to millions by making life-saving medicines more accessible. Her journey continues to inspire, shaping a future where #healthcare access knows no boundaries. #HappyBirthdayKiran

At WIRED  Health 2025 in Milan, biosimilars took center stage in a compelling discussion featuring Uwe Gudat , Chief Medical Officer at Biocon Biologics, along with Egualia – Industrie Farmaci Accessibili .  The conversation highlighted the value of biosimilars in making innovative medicine more accessible and their crucial role in supporting a sustainable healthcare system. The adoption of biosimilars is growing across Europe—and our work to increase that adoption is fundamental to improving patient care.  At Biocon Biologics, we believe that accessibility and sustainability of innovative medicines through biosimilars represent the future of healthcare. #BioconBiologicsEurope #Biosimilars #WiredHealth #WH25

#BioconBiologics will be at the JFHOD congress from March 20 to 23, 2025, at the Porte Maillot /Palais des Congrès in Paris. This new edition is organized by the “Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive” and is exclusively for health professionals. We look forward to meeting with healthcare professionals to discuss the role of biosimilars to improve patient care. This is another milestone in confirming Biocon Biologics' commitment to Gastroenterology and rewarding multidisciplinary hospital teams with innovative initiatives. Find us at our booth No #53 #BioconBiologics #BioconBiologicsEurope #JFHOD #gastroenterolgy #biosimilars

We’re excited to share this from our new corporate page — Biocon Group. Follow the page for key updates across our group companies, thought leadership, and more. Don’t forget to like, share, and stay connected!